Seeking Alpha
 

Pall Corporation (PLL)

- NYSE
  • Dec. 23, 2013, 7:32 AM
    • ATMI (ATMI) has agreed to sell its LifeSciences unit to Pall Corp. (PLL) in a deal worth $185M, with after-tax proceeds to be $165M.
    • The sale is part of ATMI's "ongoing exploration of strategic alternatives," the company said.
    • The assets of the LifeSciences business include two Belgian sites and a shared facility in Minnesota. (PR)
    | Comment!
  • Apr. 30, 2012, 3:24 AM
    Pall Corp (PLL) said yesterday it will sell some of its blood collection, filtration and processing product lines to Haemonetics Corp (HAE) for ~$550M. Separately, Haemonetics announced it will acquire the business assets of Hemerus Medical, a company that develops innovative blood technologies.
    | Comment!
Visit Seeking Alpha's
PLL vs. ETF Alternatives
Company Description
Pall Corporation supplies filtration, separation and purification technologies, using its fluid clarification and separations equipment for the removal of solid, liquid and gaseous contaminants from a wide variety of liquids and gases.